Medication Information Leaflet
Ultibro inhaler is used for the treatment of chronic obstructive pulmonary disease (COPD). COPD is a disease affecting the lungs which makes it harder for the person to breathe as the disease gets worse.
Ultibro contains two ingredients, indacaterol and glycopyrronium. Both ingredients work by relaxing the airway muscles, thus opening up the airways to make breathing easier.
If you forget to take a dose, take it as soon as you remember. Then take your next dose at the usual time. Do not take two doses to make up for the missed dose.
Inform your healthcare professional if:
Common side effects include:
These symptoms may happen but should get better over time. Check with your healthcare professionals if any of these symptoms are serious or do not go away.
In very rare cases, some patients might experience the following:
The symptoms of a drug allergy include one or more of the following:
If you experience any of these symptoms, you should stop your medication and see your healthcare professional immediately.
Store in a cool and dry place, away from direct sunlight. Keep this medication away from children.
Capsules containing the powder for inhalation for Ultibro must be stored in the original packaging to be protected from moisture. Remove the blister immediately before using.
Pack this medication into a black trash bag and seal it tightly before throwing into the rubbish chute or bin.
If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (National Healthcare Group, National University Health System and SingHealth), community pharmacies (Guardian, Unity and Watsons) and Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Last reviewed on October 2020
This article was last reviewed on Thursday, April 07, 2022